The Current State of Radiotherapy for Pediatric Brain Tumors: An Overview of Post-Radiotherapy Neurocognitive Decline and Outcomes
Authors:
Open Access
- 27 June 2022
- journal article
- review article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (7) , 1050
Abstract
Tumors of the central nervous system are the most common solid malignancies diagnosed in children. While common, they are also found to have some of the lowest survival rates of all malignancies. Treatment of childhood brain tumors often consists of operative gross total resection with adjuvant chemotherapy or radiotherapy. The current body of literature is largely inconclusive regarding the overall benefit of adjuvant chemo- or radiotherapy. However, it is known that both are associated with conditions that lower the quality of life in children who undergo those treatments. Chemotherapy is often associated with nausea, emesis, significant fatigue, immunosuppression, and alopecia. While radiotherapy can be effective for achieving local control, it is associated with late effects such as endocrine dysfunction, secondary malignancy, and neurocognitive decline. Advancements in radiotherapy grant both an increase in lifetime survival and an increased lifetime for survivors to contend with these late effects. In this review, the authors examined all the published literature, analyzing the results of clinical trials, case series, and technical notes on patients undergoing radiotherapy for the treatment of tumors of the central nervous system with a focus on neurocognitive decline and survival outcomes.Keywords
Funding Information
- United States Department of Defense
This publication has 226 references indexed in Scilit:
- On the Benefits and Risks of Proton Therapy in Pediatric CraniopharyngiomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Proton Radiotherapy for Parameningeal Rhabdomyosarcoma: Clinical Outcomes and Late EffectsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Childhood medulloblastomaCritical Reviews in Oncology/Hematology, 2011
- Intracranial Ependymomas in Children: Society of Pediatric Oncology Experience With Postoperative Hyperfractionated Local RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk MedulloblastomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Trends in childhood cancer incidence in the U.S. (1992–2004)Cancer, 2007
- Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cellsMolecular and Cellular Biochemistry, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesisJournal of Cell Biology, 2004